Mobia Medical (NASDAQ:MOBI) Releases Earnings Results, Misses Expectations By $0.27 EPS

Posted by on Aug 11th, 2026

Mobia Medical (NASDAQ:MOBI – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($1.10) earnings per share for the quarter, missing the consensus estimate of ($0.83) by ($0.27), FiscalAI reports. The firm had revenue of $13.51 million during the quarter. The company’s quarterly revenue was up 102.4% on a year-over-year basis.

Here are the key takeaways from Mobia Medical’s conference call:

  • Q2 revenue doubled year over year to $13.5 million, supported by broader Vivistim adoption, while gross margin increased to 83.2%. Management initiated 2026 revenue guidance of $54 million to $56 million, implying 69% to 75% growth.
  • Commercial expansion continued, with average active territories rising 92% year over year to 35.5 and approximately 367 Vivistim units sold in the quarter. Management expects to add roughly four to five active territories in the second half while maintaining a measured expansion strategy.
  • The May IPO generated approximately $134 million in net proceeds, leaving $177.1 million in cash and equivalents at quarter-end. The company plans to invest primarily in sales hiring, geographic expansion, patient awareness, and clinical evidence.
  • CMS assigned Vivistim’s Category 1 CPT code to New Technology APC 1580 for 2026, representing Medicare reimbursement of approximately $45,000; however, the proposed 2027 payment classification is not final until November. Commercial payer coverage remains a multiyear development effort, though some insurers are already paying claims.
  • Operating expenses grew faster than revenue, with SG&A up 85% to $26.9 million and R&D up 61% to $2.3 million. Net loss increased to $21.0 million, including a one-time, non-cash $4 million charge related to the conversion of convertible notes.

Mobia Medical Stock Down 1.2%

MOBI traded down $0.15 during midday trading on Tuesday, hitting $12.58. 97,297 shares of the company traded hands, compared to its average volume of 147,037. The firm has a 50-day moving average of $12.54. The firm has a market cap of $418.29 million and a price-to-earnings ratio of -0.65. Mobia Medical has a 52 week low of $10.19 and a 52 week high of $15.29.

Insider Activity at Mobia Medical

In related news, CFO Nelson Bunker Curnes acquired 5,000 shares of the firm’s stock in a transaction dated Tuesday, June 9th. The stock was purchased at an average cost of $12.79 per share, with a total value of $63,950.00. Following the completion of the acquisition, the chief financial officer directly owned 366,997 shares of the company’s stock, valued at approximately $4,693,891.63. This trade represents a 1.38% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Analyst Upgrades and Downgrades

MOBI has been the subject of a number of analyst reports. Zacks Research upgraded shares of Mobia Medical to a “hold” rating in a research note on Wednesday, June 3rd. JPMorgan Chase & Co. initiated coverage on shares of Mobia Medical in a report on Tuesday, June 2nd. They set an “overweight” rating and a $15.00 price target on the stock. Wolfe Research initiated coverage on shares of Mobia Medical in a research report on Tuesday, June 2nd. They set an “outperform” rating for the company. BTIG Research initiated coverage on shares of Mobia Medical in a report on Tuesday, June 2nd. They issued a “buy” rating and a $19.00 price objective for the company. Finally, Wall Street Zen raised Mobia Medical from a “sell” rating to a “hold” rating in a research report on Sunday, June 14th. Five analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $20.25.

Check Out Our Latest Stock Analysis on Mobia Medical

Mobia Medical Company Profile

(Get Free Report)

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.

Read More

Receive News & Ratings for Mobia Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mobia Medical and related companies with MarketBeat.com's FREE daily email newsletter.